| Literature DB >> 29805212 |
Qada Benameur1,2, Hassiba Tali-Maamar3, Farida Assaous3, Badia Guettou3, Meki Boutaiba Benklaouz4, Kheira Rahal3, Meriem-Hind Ben-Mahdi2,5.
Abstract
AIM: Multidrug-resistant (MDR) Enterobacteriaceae have frequently been reported, in both human and veterinary medicine, from different parts of the world as a consequence of antibiotic usage. However, there is a lack of published data regarding antimicrobial resistance in non-Escherichia coli (E. coli) Enterobacteriaceae from animals in Algeria. This study aimed to evaluate the frequency of resistance to antibiotics with a focus on quinolones and to investigate the presence of qnr genes inEnterobacteriaceaeof poultry origin.Entities:
Keywords: Algeria; Enterobacteriaceae; antimicrobial resistance; qnrS1
Year: 2018 PMID: 29805212 PMCID: PMC5960786 DOI: 10.14202/vetworld.2018.469-473
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Figure-1Antimicrobial resistance among Enterobacteriaceae. AM=Ampicillin, AMC=Amoxicillin/clavulanic acid, XNL=Ceftiofur, NA=Nalidixic acid, UB=Flumequin, CIP=Ciprofloxacin, TE=Tetracycline, SXT=Trimethoprim/sulfamethoxazole, N=Neomycin, CN=Gentamicin, C=Chloramphenicol, CT=Colistin.
MDR in Enterobacteriaceae isolates.
| Organism | Total No. | Number of MDR isolates (%) |
|---|---|---|
| 134 | 125 (93.28) | |
| 55 | 52 (94.54) | |
| 42 | 39 (92.85) | |
| 10 | 8 (80.00) | |
| 7 | 5 (71.42) | |
| 5 | 4 (80.00) | |
| Total | 253 | 233 (92.09) |
MDR=Multidrug resistant, E.coli=Escherichia coli,E. cloacae=Enterobacter cloacae,K. pneumoniae=Klebsiella pneumoniae,P. mirabilis=Proteus mirabilis,S. marcescens=Serratia marcescens, P. rettgeri=Providencia rettgeri
Enterobacteriaceae isolates tested by PCR for the determination of qnr determinants.
| Strain | Antimicrobial resistance pattern | |
|---|---|---|
| / | NA, UB, CIP, AM, SXT | |
| / | NAL, UB, CIP, AM, TE | |
| / | NAL, UB, CIP, AM, SXT, TE | |
| / | NAL, UB, CIP, AM, TE | |
| / | NAL, UB, CIP | |
| NAL, UB, CIP, AM, SXT, TE | ||
| / | NAL, UB, CIP, AM, SXT, TE, N | |
| / | NAL, UB, CIP, AM, SXT, TE | |
| / | NAL, UB, CIP, AM, AMC, SXT, TE, CN, C | |
| / | NAL, UB, SXT, TE | |
| / | NAL, UB, CIP, AM, SXT, TE, C | |
| NAL, UB, AM, AMC, TE, SXT | ||
| / | NAL, UB, AM, AMC, SXT, TE | |
| / | NAL, UB, AM, AMC, SXT, TE | |
| / | NAL, UB, CIP, AM, SXT, TE, N | |
| / | NAL, UB, CIP, AM, SXT, TE | |
| / | NAL, UB, CIP, AM, SXT, TE, N | |
| / | NAL, UB, CIP, AM, SXT, TE, CN |
NA=Nalidixic acid; UB=flumequine; CIP=Ciprofloxacin; SXT=Trimethoprim/sulfamethoxazole; TE=Tetracycline; N=Neomycin; CN=Gentamicin; C=Chloramphenicol, E.coli=Escherichia coli, E. cloacae=Enterobacter cloacae,K. pneumoniae=Klebsiella pneumoniae,P. rettgeri=Providencia rettgeri